Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01856023 | HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma(PROCLIVITY02) | terminated | Phase 4 | 29 | Clinigen, Inc.INDUSTRY | 1 | Dec 5, 2023 | clinicaltrials |
| NCT01683188 | HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma(PROCLIVITY01) | terminated | Phase 4 | 53 | Clinigen, Inc.INDUSTRY | 1 | Feb 1, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Dec 5, 2023source: clinicaltrials